Published October 2008 | Version v1
Journal article

Dosimetric comparisons of helical tomotherapy and step-and-shoot intensity-modulated radiotherapy in nasopharyngeal carcinoma

  • 1. Department of Radiation Oncology, Chang Gung Memorial Hospital-Kaohsiung Medical Center, Chang Gung University College of Medicine, Taiwan (China)
  • 2. National Kaohsiung University of Applied Sciences, Kaohsiung, Taiwan (China)
  • 3. Department of Radiation Oncology, Kaohsiung Yuan's General Hospital, Taiwan (China)
  • 4. Department of Radiological Technology, Central Taiwan University of Science and Technology, Taiwan (China)

Description

Purpose: The study evaluates and quantifies the potential dosimetric gains of helical tomotherapy (HT) versus step-and-shoot intensity-modulated radiotherapy (SaS-IMRT) for nasopharyngeal carcinoma (NPC). Materials and methods: Twenty consecutive NPC patients curatively treated by HT were examined. Each case was planned by HT and SaS-IMRT (ADAC Pinnacle3) planning system, respectively. Dose plans were compared using dose volume histograms (DVH), conformity index (CI), homogeneity index (HI), and minimal dose to 1 cc (Dmin1cc) of the planned target volume (PTV) and a comprehensive quality index (CQI) of ten organs at risk (OARs). The prescribed dose/fractionation was 72 Gy to the PTV, 64.8 Gy to the elective PTV, and 54 Gy to the clinically negative neck region. The plan of 54 Gy to the PTV (PTV54) was used to evaluate the CI and HI in the target. The cumulative doses of the three PTV plans to the OARs were calculated. Results: We observed the HT plans significantly improved the CI (improvement ratio: 11.9 ± 5.5%) and HI (improvement ratio: 8.8 ± 1.5%) of the PTV54 compared with SaS-IMRT plans. In addition, the mean/maximal dose of most of the OARs except chiasm was significantly reduced in HT plans, with the CQI of 0.92 ± 0.08. A negative result of HT in chiasm was observed but only significantly revealed in cases without skull base infiltration. Conclusions: A dosimetric gain in CI and HI of PTV and sparing of OARs was significantly obtained in HT versus SaS-IMRT plans in NPC patients. Whether such dosimetric superiority in HT could transfer into clinical advantages needs further investigation

Availability note (English)

Available from http://dx.doi.org/10.1016/j.radonc.2008.05.010

Additional details

Identifiers

DOI
10.1016/j.radonc.2008.05.010;
PII
S0167-8140(08)00263-6;

Publishing Information

Journal Title
Radiotherapy and Oncology
Journal Volume
89
Journal Issue
1
Journal Page Range
p. 89-96
ISSN
0167-8140
CODEN
RAONDT

Optional Information

Copyright
Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.